Company intelligence / Profile preview

SoCal Biosciences

San Diego, California, United Statessocalbiosci.com ↗

Ownership: Private
Development stage: Other

Overview

SoCal Biosciences is an active, woman-owned bioanalytical contract research organization specializing in assay development and analytical support for mRNA, oligonucleotide, and large molecule therapeutics. The company offers end-to-end services including new drug candidate screening, biodistribution studies for RNA platforms, pharmacokinetic/pharmacodynamic analysis, immunogenicity testing, and biomarker assays. Founded by Dr. Patty Limphong in 2022 in San Diego, it emphasizes quality data delivery with expertise in RNA-based therapeutics.

Therapeutic areas: Other
Modalities: mRNA-based drugsOligonucleotidesLarge molecules (including proteins and biologics)
Industry: Contract Research Organization

Partnerships

No major pharmaceutical or biotech partnerships publicly listed as of June 2025.

Beyond the preview

Go deeper on SoCal Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SoCal Biosciences.

Explore the full profile